Literature DB >> 12594448

The problem of decompensated heart failure: nomenclature, classification, and risk stratification.

G Michael Felker1, Kirkwood F Adams, Marvin A Konstam, Christopher M O'Connor, Mihai Gheorghiade.   

Abstract

Despite its high prevalence and significant rates of associated morbidity and mortality, the syndrome of decompensated heart failure remains poorly defined and vastly understudied. Few high-quality epidemiologic studies, randomized controlled trials, or published guidelines are available to guide the management of this complex disease. In addition, there is no consensus definition of the clinical problem that it presents, no agreed upon nomenclature to describe its clinical features, and no recognized classification scheme for its patient population; all of which has contributed to the lack of therapeutic development in this critical arena of cardiovascular disease. This review outlines the scope of the problem and proposes a system of nomenclature and classification sufficiently simple for general acceptance among clinicians while still encompassing the heterogeneity of the patient population. It also defines the current understanding of strategies for risk stratification in the setting of decompensated heart failure.

Entities:  

Mesh:

Year:  2003        PMID: 12594448     DOI: 10.1067/mhj.2003.150

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  35 in total

1.  Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer.

Authors:  Larry A Allen; Marianne Ulcickas Yood; Edward H Wagner; Erin J Aiello Bowles; Roy Pardee; Robert Wellman; Laurel Habel; Larissa Nekhlyudov; Robert L Davis; Adedayo A Onitilo; David J Magid
Journal:  Med Care       Date:  2014-05       Impact factor: 2.983

Review 2.  Management of acute decompensated heart failure.

Authors:  Larry A Allen; Christopher M O'Connor
Journal:  CMAJ       Date:  2007-03-13       Impact factor: 8.262

3.  Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure.

Authors:  Hakki Kaya; Recep Kurt; Osman Beton; Ali Zorlu; Hasan Yucel; Hakan Gunes; Didem Oguz; Mehmet Birhan Yilmaz
Journal:  Tex Heart Inst J       Date:  2017-02-01

Review 4.  Assessment of quality of life in severe heart failure.

Authors:  Prashant Vaishnava; Eldrin F Lewis
Journal:  Curr Heart Fail Rep       Date:  2007-09

Review 5.  A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods.

Authors:  Mark Oremus; Robert McKelvie; Andrew Don-Wauchope; Pasqualina L Santaguida; Usman Ali; Cynthia Balion; Stephen Hill; Ronald Booth; Judy A Brown; Amy Bustamam; Nazmul Sohel; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

6.  Acute pulmonary edema in patients with reduced left ventricular ejection fraction is associated with concentric left ventricular geometry.

Authors:  Junichi Imanishi; Kenji Kaihotsu; Sachiko Yoshikawa; Makoto Nishimori; Naohiko Sone; Tomoyuki Honjo; Masanori Iwahashi
Journal:  Int J Cardiovasc Imaging       Date:  2017-08-02       Impact factor: 2.357

Review 7.  The challenge of acute decompensated heart failure.

Authors:  Faiez Zannad; Chris Adamopoulos; Alexandre Mebazaa; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2006-06       Impact factor: 4.214

Review 8.  Venous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect?

Authors:  Paolo C Colombo; Amanda C Doran; Duygu Onat; Ka Yuk Wong; Myra Ahmad; Hani N Sabbah; Ryan T Demmer
Journal:  Curr Heart Fail Rep       Date:  2015-06

9.  Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial.

Authors:  Horng H Chen; Omar F AbouEzzeddine; Kevin J Anstrom; Michael M Givertz; Bradley A Bart; G Michael Felker; Adrian F Hernandez; Kerry L Lee; Eugene Braunwald; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2013-09-01       Impact factor: 8.790

10.  Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study.

Authors:  Robert J MacFadyen; J Christopher Gorski; D Craig Brater; Allan D Struthers
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.